BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36005472)

  • 1. What Is in the Myopathy Literature?
    Al-Lahham T; Lacomis D
    J Clin Neuromuscul Dis; 2022 Sep; 24(1):38-48. PubMed ID: 36005472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G; Antonini G; Garibaldi M
    Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated necrotizing myopathy: Unusual presentations of a treatable disease.
    Nicolau S; Milone M; Tracy JA; Mills JR; Triplett JD; Liewluck T
    Muscle Nerve; 2021 Dec; 64(6):734-739. PubMed ID: 34617293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Becker Muscular Dystrophy Accompanied by Anti-HMGCR Antibody-positive Immune-mediated Necrotizing Myopathy.
    Munekane A; Ohsawa Y; Okubo M; Nagai T; Nishimura H; Nishino I; Sunada Y
    Intern Med; 2023 May; 62(9):1345-1349. PubMed ID: 36130887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
    Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
    BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired necrotizing myopathies].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2013 Jun; 34(6):363-8. PubMed ID: 22998975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pathogenesis of anti-signal recognition particle necrotizing myopathy: A Review.
    Qiu R; Wang Z; Wei X; Sui H; Jiang Z; Yu XF
    Biomed Pharmacother; 2022 Dec; 156():113936. PubMed ID: 36411623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y; Benveniste O; Stenzel W; Boyer O
    Nat Rev Rheumatol; 2020 Dec; 16(12):689-701. PubMed ID: 33093664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent positive anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase antibody with reducing body myopathy: Possible double trouble.
    Tanboon J; Sanmaneechai O; Charuvanij S; Sangruchi T; Galindo-Feria AS; Lundberg IE; Ohnuki Y; Shiina T; Suzuki S; Nishino I
    Neuromuscul Disord; 2019 Jul; 29(7):543-548. PubMed ID: 31204143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential diagnosis of necrotizing myopathy.
    Selva-O'Callaghan A; Trallero-Araguás E; Milisenda JC; Grau-Junyent JM
    Curr Opin Rheumatol; 2021 Nov; 33(6):544-553. PubMed ID: 34482348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase necrotizing myopathy masquerading as a muscular dystrophy in a child.
    Mohassel P; Foley AR; Donkervoort S; Fequiere PR; Pak K; Bönnemann CG; Mammen AL
    Muscle Nerve; 2017 Dec; 56(6):1177-1181. PubMed ID: 28066895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune myopathies: autoantibodies, phenotypes and pathogenesis.
    Mammen AL
    Nat Rev Neurol; 2011 Jun; 7(6):343-54. PubMed ID: 21654717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological Features of Myositis and Necrotizing Myopathy: How to Distinguish between Myositis and Muscular Dystrophy on Muscle Pathology].
    Saito Y; Nishino I
    Brain Nerve; 2021 Feb; 73(2):147-159. PubMed ID: 33561829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Mediated Necrotizing Myopathy: Where do we Stand?
    Mohammed AGA; Gcelu A; Moosajee F; Botha S; Kalla AA
    Curr Rheumatol Rev; 2019; 15(1):23-26. PubMed ID: 29623846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins.
    Lahaye C; Beaufrére AM; Boyer O; Drouot L; Soubrier M; Tournadre A
    Joint Bone Spine; 2014 Jan; 81(1):79-82. PubMed ID: 23953224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Features of Anti-Ku Myositis.
    Oyama M; Holzer MT; Ohnuki Y; Saito Y; Nishimori Y; Suzuki S; Shiina T; Leonard-Louis S; Benveniste O; Schneider U; Stenzel W; Nishino I; Suzuki S; Uruha A
    Neurology; 2024 Apr; 102(8):e209268. PubMed ID: 38547417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A young female case of asymptomatic immune-mediated necrotizing myopathy: a potential diagnostic option of antibody testing for rhabdomyolysis.
    Sasaki R; Yunoki T; Nakano Y; Fukui Y; Takemoto M; Morihara R; Katsuyama E; Nishino I; Yamashita T
    Neuromuscul Disord; 2023 Feb; 33(2):183-186. PubMed ID: 36652875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which nonautoimmune myopathies are most frequently misdiagnosed as myositis?
    Mammen AL
    Curr Opin Rheumatol; 2017 Nov; 29(6):618-622. PubMed ID: 28832350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Necrotizing myopathies: beyond statins.
    Mammen AL
    Curr Opin Rheumatol; 2014 Nov; 26(6):679-83. PubMed ID: 25203117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.